|
|
Volumn 6, Issue 4, 1996, Pages 379-384
|
|
Anxiolytics: Patent analysis 1990-1995
a
a
NONE
(United Kingdom)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA;
4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE;
ABECARNIL;
ANTIEMETIC AGENT;
ANXIOLYTIC AGENT;
BENZODIAZEPINE DERIVATIVE;
BRETAZENIL;
BUSPIRONE;
CHLORDIAZEPOXIDE;
CHOLECYSTOKININ B RECEPTOR ANTAGONIST;
CITALOPRAM;
DIAZEPAM;
FLESINOXAN;
GABAERGIC RECEPTOR AFFECTING AGENT;
GEPIRONE;
IPSAPIRONE;
LORAZEPAM;
ONDANSETRON;
PAZINACLONE;
RITANSERIN;
SEROTONIN 1A AGONIST;
SEROTONIN 2 ANTAGONIST;
SEROTONIN RECEPTOR AFFECTING AGENT;
SEROTONIN UPTAKE INHIBITOR;
SERTINDOLE;
TANDOSPIRONE;
UNINDEXED DRUG;
ANIMAL MODEL;
ANXIETY NEUROSIS;
CLINICAL TRIAL;
COMPULSION;
DEPRESSION;
DROWSINESS;
DRUG INDUSTRY;
DRUG RESEARCH;
HUMAN;
NONHUMAN;
OBSESSION;
PANIC;
PATENT;
REVIEW;
WITHDRAWAL SYNDROME;
|
|
EID: 0029965326
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.6.4.379 Document Type: Review |
|
Times cited : (2)
|
|
References (0)
|
